Early changes in insulin secretion and action induced by high-fat diet are related to a decreased sympathetic tone

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 1 51-1, 2005, Pages

  Cruciani Guglielmacci, C ^a,b   Vincent Lamon, M ^a   Rouch, C ^a   Orosco, M ^a   Ktorza, A ^a   Magnan, C ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Insulin secretion and hepatic sensitivity

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; FATTY ACID; GLUCOSE; INSULIN; NORADRENALIN; OXYMETAZOLINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NEUROPATHY; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSLIPIDEMIA; EXTRACELLULAR SPACE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HORMONE ACTION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; LIVER METABOLISM; MALE; MICRODIALYSIS; NERVOUS SYSTEM FUNCTION; NONHUMAN; OBESITY; PANCREAS; PRIORITY JOURNAL; PROVOCATION TEST; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SYMPATHETIC TONE; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ZONA INCERTA;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; EATING; HYPERGLYCEMIA; HYPERINSULINISM; HYPOTHALAMUS; INSULIN; LIVER; MALE; NOREPINEPHRINE; OXYMETAZOLINE; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS;

EID: 11144320678     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00225.2004     Document Type: Article

References (54)

1. Adeghate E, Ponery AS, and Sheen R. Streptozotocin-Induced diabetes mellitus is associated with increased pancreatic tissue levels of noradrenaline and adrenaline in the rat. Pancreas 22: 311-316, 2001.
2. Ahrén B. Autonomic regulation of islet hormone secretion-implication for health and disease. Diabetologia 43: 393-410, 2000.
3. Ahren B, Gudbjartsson T, Al-Amin AN, Martensson H, Myrsen-Axcrona U, Karlsson S, Mulder H, and Sundler F. Islet perturbations in rats fed a high-fat diet. Pancreas 18: 75-83, 1999.
4. Angel I, Niddam R, and Langer SZ. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia. J Pharmacol Exp Ther 254: 877-882, 1990.
5. Bays H, Mandarino L, and DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89: 463-478, 2004.
6. Berk PD and Stump DD. Mechanisms of cellular uptake of long chain free fatty acids. Mol Cell Biochem 192: 17-31, 1999.
7. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 111: 121-124, 2003.
8. Brodie B, Costa E, Dlabec A, Neff N, and Snookler H. Application of steady state kinetics to the estimation of synthesis rate and turnover time in tissue catecholamines. J Pharmacol Exp Ther 154: 493-498, 1966.
9. Burcelin R, Dolci W, and Thorens B. Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. Diabetes 49: 1635-1642, 2000.
10. Chalkley SM, Hettiarachchi M, Chisholm DJ, and Kraegen EW. Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am J Physiol Endocrinol Metab 282: E1231-E1238, 2002.
11. Chavez M, Seeley RJ, Havel PJ, Friedman MI, Matson CA, Woods SC, and Schwartz MW. Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes. J Clin Invest 102: 340-346, 1998.
12. Chong W, Li LH, Lee K, Lee MH, Park JB, and Ryu PD. Subtypes of alpha1- and alpha2-adrenoceptors mediating noradrenergic modulation of spontaneous inhibitory postsynaptic currents in the hypothalamic paraventricular nucleus. J Neuroendocrinol 16: 450-457, 2004.
13. DeFronzo RA. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 35: 389-397, 1992.
14. Felber JP. From obesity to diabetes. Pathophysiological considerations. Int J Obes Relat Metab Disord 16: 937-952, 1992.
15. Felber JP and Golay A. Pathways from obesity to diabetes. Int J Obes Relat Metab Disord 26, Suppl 2: S39-S45, 2002.
16. Hansen BC and Bodkin NL. Beta-cell hyperresponsiveness: earliest event in development of diabetes in monkeys. Am J Physiol Regul Integr Comp Physiol 259: R612-R617, 1990.
17. Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 226: 963-977, 2001.
18. Hevener AL, Bergman RN, and Donovan CM. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 46: 1521-1525, 1997.
19. Hogikyan RV and Supiano MA. Arterial α-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol Endocrinol Metab 266: E717-E724, 1994.
20. Horvath TL, Diano S, Sotonyi P, Heiman M, and Tschop M. Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology 142: 4163-4169, 2001.
21. Konturek SJ, Zabielski R, Konturek JW, and Czarnecki J. Neuroendocrinology of the pancreas; role of brain-gut axis in pancreatic secretion. Eur J Pharmacol 481: 1-14, 2003.
22. Korner J and Leibel RL. To eat or not to eat: how the gut talks to the brain. N Engl J Med 349: 926-928, 2003.
23. Kreier F, Kalsbeek A, Ruiter M, Yilmaz A, Romijn JA, Sauerwein HP, Fliers E, and Buijs RM. Central nervous determination of food storage-a daily switch from conservation to expenditure: implications for the metabolic syndrome. Eur J Pharmacol 480: 51-65, 2003.
24. Kreier F, Yilmaz A, Kalsbeek A, Romijn JA, Sauerwein HP, Fliers E, and Buijs RM. Hypothesis: shifting the equilibrium from activity to food leads to autonomic unbalance and the metabolic syndrome. Diabetes 52: 2652-2656, 2003.
25. Kusunoki M, Tsutsumi K, Hara T, Ogawa H, Nakamura T, Miyata T, Sakakibara F, Fukuzawa Y, Suga T, Kakumu S, and Nakaya Y. Correlation between lipid and glycogen contents in liver and insulin resistance in high-fat-fed rats treated with the lipoprotein lipase activator NO-1886. Metabolism 51: 792-795, 2002.
26. la Fleur SE, Kalsbeek A, Wortel J, and Buijs RM. Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver. Brain Res 871: 50-56, 2000.
27. Lam TK, Carpentier A, Lewis GF, van de Werve G, Fantus IG, and Giacca A. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab 284: E863-E873, 2003.
28. Levin B. Reduced norepinephrine turnover in organs and brains of obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 268: R389-R394, 1995.
29. Levin B, Triscari J, and Sullivan A. Relationship between sympathetic activity and diet-induced obesity in two rat strains. Am J Physiol Regul Integr Comp Physiol 245: R364-R371, 1983.
30. Levin BE and Dunn-Meynell AA. Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 283: R941-R948, 2002.
31. Magnan C, Collins S, Berthault M, Kassis N, Vincent M, Gilbert M, Péicaud L, Ktorza A, and Assimacopoulos-Jeannet F. Lipid infusion lowers sympathetic nervous activity and leads to increased β-cell responsiveness to glucose. J Clin Invest 103: 413-419, 1999.
32. Marx J. Cellular warriors at the battle of the bulge. Science 299: 846-849, 2003.
33. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51: 7-18, 2002.
34. Meigs JB. Epidemiology of the metabolic syndrome, 2002. Am J Manag Care 8: S283-S286, 2002.
35. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409: 194-198, 2001.
36. Niijima A. Neural mechanisms in the control of blood glucose concentration. J Nutr 119: 833-840, 1989.
37. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43: 533-549, 2000.
38. a. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1986.
39. Randich A, Chandler PC, Mebane HC, Turnbach ME, Meller ST, Kelm GR, and Cox JE. Jejunal administration of linoleic acid increases activity of neurons in the paraventricular nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 286: R166-R173, 2004.
40. Randich A, Spraggins DS, Cox JE, Meller ST, and Kelm GR. Jejunal or portal vein infusions of lipids increase hepatic vagal afferent activity. Neuroreport 12: 3101-3105, 2001.
41. Ravussin E. Energy metabolism in obesity. Studies in the Pima Indians. Diabetes Care 16: 232-238, 1993.
42. Reimer MK, Pacini G, and Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144: 916-921, 2003.
43. Roehrig KL and Allred JB. Direct enzymatic procedure for the determination of liver glycogen. Anal Biochem 58: 414-421, 1974.
44. Rouch C, Meile MJ, and Orosco M. Extracellular hypothalamic serotonin and plasma amino acids in response to sequential carbohydrate and protein meals. Nutr Neurosci 6: 117-124, 2003.
45. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, and Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
46. Supiano MA, Hogikyan RV, Stoltz AM, Orstan N, and Halter JB. Regulation of venous α-adrenergic responses in older humans. Am J Physiol Endocrinol Metab 260: E599-E607, 1991.
47. Taylor SI, Accili D, and Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43: 735-740, 1994.
48. Unger R. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44: 863-870, 1995.
49. Unger RH. Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144: 5159-5165, 2003.
50. Unger RH and Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15: 312-321, 2001.
51. Valette H, Deleuze P, Syrota A, Delforge J, Crouzel C, Fuseau C, and Loisance D. Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: a PET study. J Nucl Med 36: 140-146, 1995.
52. Wierup N, Yang S, McEvilly RJ, Mulder H, and Sundler F. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem 52: 301-310, 2004.
53. Yoshihara F, Kojima M, Hosoda H, Nakazato M, and Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care 5: 391-395, 2002.
54. Zoukos Y, Thomaides T, Pavitt DV, Leonard JP, Cuzner ML, and Mathias CJ. Up-regulation of beta-adrenoceptors on circulating mononuclear cells after reduction of central sympathetic outflow by clonidine in normal subjects. Clin Auton Res 2: 165-170, 1992.